May 2010

Last Word

April 29, 2010

The Impact What will be the impact of the federal legislation requiring companies to disclose financial transactions with providers? Fisher. The federal legislation is not going to hugely impact pharmaceutical companies. The PhRMA guidelines cover a lot of this already. The biggest change is how companies maintain and manage all of the information and provide […]

Electronic Records: Beneficial to All, But At a Price

April 28, 2010

The next five years will represent significant growth toward the implementation of electronic medical records (EMRs) in both hospitals and physician offices. Several ­factors are driving this new momentum, including the recent release of Notice for Proposed Rulemaking on the electronic health record certification process, an increased level of optimism by physicians to implement EMR […]

Haiti: A Beacon of Hope Through the Rubble

April 28, 2010

The pharmaceutical and biotech industry is one built upon the foundations of human fragility. It is a business of identifying physiological weaknesses and developing the medicines and products to address those faults, thus resulting in an enhanced standard of living and optimum health for the human race. It is a profession with the power to […]

Getting the Most From Distance Learning: Mistakes to Avoid

April 28, 2010

It’s no secret that the use of distance learning is on the rise. As the economy remains shaky and budgets remain tight, pharmaceutical company training departments are working diligently to squeeze every drop of value from each dollar they spend. Training teams know that distance learning can help them maximize the returns on their training […]

Evolution in Action

April 28, 2010

As technology and medicine have advanced over the last two decades, the strategies adopted by pharmaceutical sales and commercial models have fallen out of synch. Companies regressed from customer-focused, consultative models to a more quantitative reach and frequency approach, with a strong reliance on pitches, gifts, and free samples. This model digressed from quality of […]

VIEW on Sales: A Personal Touch

April 28, 2010

Most pharmaceutical industry leaders agree that the customer remains the one constant in the shifting sales-force model. “Our goal as an industry has always been to provide physicians with meaningful information that translates into sound decision-making around their patients,” says Amy Jenner, a divisional VP of sales for specialty care at Pfizer. “I don’t believe […]

The Future of Market Research In One Word: Change

April 28, 2010

The resounding takeaway from the recent Pharmaceutical Marketing Research Group’s annual conference in April was that change, and in some cases revolutionary change, will be necessary to address current and future market conditions. One of the keynote sessions, “CEO Reflections on a Tumultuous Year and Predictions for an Uncertain Future,” which was moderated by Brian […]

The Healthcare Businesswomen’s Association’s Rising Stars

April 28, 2010

Amy Weickert. InfoMedics. Leaders need to have a clear vision and be able to articulate that vision and consistently drive others to believe that they can accomplish it. Leaders who I have admired are honest, communicate well, and create a positive environment of trust among their team members, as well as one of mutual respect […]

Unbranded Efforts Are Making a Promotional Comeback

April 28, 2010

In the world before DTC, pharmaceutical companies invested in unbranded promotion to educate physicians about disease states and to create market growth. Then DTC came along and replaced most unbranded promotional efforts. But the unbranded message is making a comeback today; our experts say this movement is being driven by more stringent regulations, increased FDA […]

Molecular Diagnostics Creating More Focused Treatments

April 28, 2010

Experts have been saying for years that molecular diagnostics will transform not only the way prescription drugs are developed and dispensed, but also the entire healthcare delivery system. Their predictions are coming true: the molecular diagnostic market is exploding, with reported value estimated to reach $7 billion by 2011. New biomarkers are continually being discovered, […]

Talent Pool

April 28, 2010

Pharmaceutical POOL Kristin PECK Pfizer Names Head of Business ­Development Global healthcare company Pfizer has named Kristin Peck to succeed the retiring William Ringo as senior VP of worldwide business development, strategy, and innovation. Ms. Peck joined Pfizer’s strategic planning organization in 2004 and most recently served as senior VP of worldwide strategy and innovation. […]

PharmaTrax

April 28, 2010

Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Most Doctors Prefer CME Promotion by E-mail Pharma Advised to Focus Social Media Efforts on Education Pharma Ramps Up ­Regulatory Affairs Delivering Articulate ­Message Key to ­Managed Markets Access Sidebar: Q. Which of the following global ­activities have the greatest impact on strategic choices? Pharma […]

E-Media

April 28, 2010

New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: BioClinica Launches System for Clinical-Trial ­Supply Planning New Quintiles Tool Accelerates Trial Recruitment Sidus Group Adds Life-Sciences Hosting ­Solution Paragon, NextDocs Collaborate on Clinical ­Optimization Solutions OmniConnect Enables Real-Time Data Integration from Multiple Sources On-Demand Information ­Management System Targets Smaller Labs Kendle’s Biostatistics Infrastructure Increases […]

What’s New

April 28, 2010

New Healthcare-related Products, Services, and Companies Featured Briefs: TGaS Model Helps Solve Managed Markets Staffing Dilemma Razorfish Launches Independent, ­Dedicated Health Division FDA, NIH Collaborate to Speed Release of Medical Innovations Sidebar: On The Shelves PSKW Adds Loyalty Relationship Portfolio PharmaTelevision Expands Biopharma Media Service Offerings Sidebar: Around the Globe Follow Up THE FOOD AND […]

Case Study: EpiCept

April 28, 2010

Named Patient Programs Provide Pre-Launch Access to Drugs The dire outlook facing AML patients motivated a company to provide its drug in advance of the commercial launch. Jack V. Talley President and CEO, ­EpiCept EpiCept is a specialty pharmaceutical company that focuses on fulfilling unmet medical needs in cancer treatment and pain management. The company […]

UpFront

April 28, 2010

Market Report U.S. Prescription Sales Grow U.S. sales of ethical ­pharmaceuticals and insulins through retail and non-retail channels grew 5.1% in 2009, reaching $300.3 billion, ­compared with growth of 1.8% in 2008. While the 32 innovative products launched last year brought important new treatment options to patients in a number of disease areas, including cancer, […]

Letter from the Editor

April 28, 2010

Forms, forms, and more forms… We’ve probably all been hospitalized at one time in our lives, and during whatever span of time we had to spend there, we probably experienced one or two moments of concern when we were repeatedly asked the same questions by a variety of well-meaning practitioners. Several times during my own […]

FEEDBACK